Patrick Soon-Shiong says NantOmics is Cancer Social Network.
“Patrick Soon-Shiong, the physician who founded and sold two drug companies to become Los Angeles’s wealthiest resident, is starting a new company with the goal of changing the way cancer is attacked.
Called NantOmics, the company will build on the knowledge Soon-Shiong, 60, said he gained from Abraxane, the cancer treatment he developed and sold to Celgene Corp. (CELG) in 2010 for $2.9 billion. The medicine wraps a chemotherapy in a human protein called albumin that aims to more efficiently ferry cancer-killing agents to their target.
Celgene reported last week that the drug helped patients with advanced pancreatic cancer live a median 1.8 months longer than a standard treatment, a benefit for people battling one of the deadliest cancers. Soon-Shiong said he wants to extend that benefit by combining new diagnostic technologies and therapeutic strategies to improve care…”
READ FULL ARTICLE [web]